Abstract
Background and Purpose: Motor network flexibility, the ability to switch between different neural network connectivity configurations, is a key feature of normal motor behavior and motor learning. Limited flexibility of the motor system to adapt to environmental stimuli is a pervasive feature of mobility impairment in chronic stroke survivors. The reduced capacity to modulate cortical motor network connectivity during motor behavior has been implicated as a key neural mechanism for constrained flexibility of the motor system. However, whether the theory of reduced cortical motor network flexibility prevails in the lower limb corticomotor system and in the context of functional lower limb motor behaviors remains unknown. In this study, we tested the capacity of the lower limb motor cortex to react to external stimuli using transcranial magnetic stimulation (TMS) and the ability of the cortex to modulate motor network connectivity during lower limb motor activity in a group of chronic stroke survivors and age-matched older adult controls. We evaluated the relationship between activity-dependent modulation of TMS-evoked motor cortical connectivity and post-stroke clinical and biomechanical walking function as well as corticospinal excitability of the paretic leg. Methods: Chronic stroke survivors (n=14) and older adults (n=9) completed concurrent TMS-electroencephalography (EEG) testing, clinical evaluation, and biomechanical walking assessment. EEG was recorded during TMS delivered over the contralesional (c)M1 and ipsilesional (i)M1 during rest and active ipsilateral plantarflexion. Interhemispheric connectivity was calculated as the post-TMS (0-300ms) imaginary part of coherence value between electrodes overlying cM1 and iM1 within the beta frequency range (15-30Hz). We compared cM1 and iM1 TMS-evoked beta coherence between groups during rest and active conditions and tested associations with walking impairment and paretic leg corticospinal excitability in stroke survivors. Results: In older adult controls, TMS-evoked beta coherence was greater compared to stroke survivors and showed a reduction from rest during active motor conditions regardless of hemisphere. Stroke survivors showed lower TMS-evoked beta coherence during cM1 TMS and a lack of modulation between rest and active conditions. Higher cM1 TMS-evoked beta coherence at rest and reduction of beta coherence during paretic plantarflexion was associated with greater paretic ankle moment during walking and lower levels of clinical lower limb motor impairment. Increased beta coherence during iM1 TMS at rest was associated with the presence of a MEP in the paretic lower limb. Conclusions: We found that, like findings in animal models and the upper limb, the lower limb corticomotor system showed reduced cortical network reactivity to external stimuli (TMS), and impaired modulation of cortical network connectivity during lower limb motor activity after stroke. Impaired cortical reactivity and modulation were associated with post-stroke clinical and biomechanical walking function and corticomotor excitability of the paretic leg, supporting the link between cortical network connectivity, motor network flexibility and lower limb motor behavior. These findings have important implications for the development of targeted and individualized treatments to improve lower limb disability in stroke survivors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the American Heart Association [AHA00035638] and the Eunice Kennedy Shriver National Institutes of Child Health & Human Development of the National Institutes of Health [F32HD096816 and K12HD055931].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participant provided written informed consent. This protocol was approved by Emory University Institutional Review Board.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
available upon request and signing of a data sharing agreement.
